Financial News
Seres Therapeutics Inc (NQ: MCRB )
0.8006
+0.0106
(+1.34%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
All News about Seres Therapeutics Inc
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2023/roce_image_1414.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230509005469/en/1787542/5/SERES_Logo_Full_Color_HiRes.jpg)
![](/next-assets/images/schema-image-default.png)
Preview: Seres Therapeutics's Earnings
May 08, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where Seres Therapeutics Stands With Analysts
April 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/27/mcrb.png?width=1200&height=800&fit=crop)
Why Seres Therapeutics Shares Are Surging Thursday Morning
April 27, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230509005470/en/1787543/5/SERES_Logo_Full_Color_HiRes.jpg)
![](https://mms.businesswire.com/media/20230508005165/en/1785608/5/NHS_Logo_RGB.jpg)
Via Business Wire
![](https://g.foolcdn.com/editorial/images/728782/parabola.jpg)
![](/next-assets/images/schema-image-default.png)
Where Seres Therapeutics Stands With Analysts
March 08, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Seres Therapeutics Earnings Preview
March 06, 2023
Via Benzinga
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2023/04/28/mastercard_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/28/snap_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230427005329/en/1776354/22/SERES_Logo_Full_Color_%281%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/stock_charts_3_0.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230426006066/en/1775977/5/NHS_Logo.jpg)
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/04/26/amazon_-logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/17/satsuma_pharmaceuticals_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://g.foolcdn.com/editorial/images/727011/blood-sample.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/03/10/dices-over-newspaper-2656028_1920.jpg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230307005092/en/1730227/22/PRESS_RELEASE_LOGO_Seres.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230228005113/en/1722984/22/PRESS_RELEASE_LOGO_Seres.jpg)
![](https://mms.businesswire.com/media/20230227005181/en/1722983/22/PRESS_RELEASE_LOGO_Seres.jpg)
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.